ANPAC BIO-MEDICAL SCIENCE COMPANY Trademark
Trademark Overview
On Thursday, December 13, 2018, a trademark application was filed for ANPAC BIO-MEDICAL SCIENCE COMPANY with the United States Patent and Trademark Office. The USPTO has given the ANPAC BIO-MEDICAL SCIENCE COMPANY trademark a serial number of 88227927. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, November 13, 2025. This trademark is owned by Anpac Bio-medical Science Co., Ltd.. The ANPAC BIO-MEDICAL SCIENCE COMPANY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Scientific and technological services, namely, scientific research, analysis and design in the fields of oncology and chronic diseases; Design and development of medical diagnostic products relating to cancer detection; Providing medical testing services and information in the field of cancer research and disease classification
General Information
| Serial Number | 88227927 |
| Word Mark | ANPAC BIO-MEDICAL SCIENCE COMPANY |
| Filing Date | Thursday, December 13, 2018 |
| Status | 702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED |
| Status Date | Thursday, November 13, 2025 |
| Registration Number | 5819451 |
| Registration Date | Tuesday, July 30, 2019 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 14, 2019 |
Trademark Statements
| Goods and Services | Scientific and technological services, namely, scientific research, analysis and design in the fields of oncology and chronic diseases; Design and development of medical diagnostic products relating to cancer detection; Providing medical testing services and information in the field of cancer research and disease classification |
| NOT AVAILABLE | "BIO-MEDICAL SCIENCE COMPANY" |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, January 5, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | Saturday, January 1, 2011 |
| First Use In Commerce Date | Saturday, January 1, 2011 |
Trademark Owner History
| Party Name | Anpac Bio-medical Science Co., Ltd. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 13 - Limited Partnership |
| Address | Conneautville, PA 16406 |
| Party Name | Anpac Bio-medical Science Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 13 - Limited Partnership |
| Address | Conneautville, PA 16406 |
| Party Name | Anpac Bio-medical Science Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 13 - Limited Partnership |
| Address | Conneautville, PA 16406 |
Trademark Events
| Event Date | Event Description |
| Monday, December 17, 2018 | NEW APPLICATION ENTERED |
| Saturday, January 5, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, March 12, 2019 | ASSIGNED TO EXAMINER |
| Monday, March 18, 2019 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, March 18, 2019 | EXAMINERS AMENDMENT E-MAILED |
| Monday, March 18, 2019 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, March 18, 2019 | EXAMINER'S AMENDMENT ENTERED |
| Monday, March 18, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, April 8, 2019 | ASSIGNED TO LIE |
| Wednesday, April 24, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 14, 2019 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 14, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 30, 2019 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, July 30, 2024 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Thursday, July 24, 2025 | TEAS SECTION 8 & 15 RECEIVED |
| Thursday, November 13, 2025 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Thursday, November 13, 2025 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| Thursday, November 13, 2025 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
